CD44 has been shown to anchor the proteolytically-active form of MMP-9 to the cell surface [19] while the constitutive expression of either the transcription factor ID-1 or the receptor DDR1 has been reported to increase the activity of MMP-9 and the invasiveness of human cancer cells (35–39). The gene discussed is MMP9; the disease is cancer.